Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H8N2O3S |
| Molecular Weight | 272.279 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=CC=C(OC2=CC=C(C=C2)N=C=S)C=C1
InChI
InChIKey=SVMGVZLUIWGYPH-UHFFFAOYSA-N
InChI=1S/C13H8N2O3S/c16-15(17)11-3-7-13(8-4-11)18-12-5-1-10(2-6-12)14-9-19/h1-8H
| Molecular Formula | C13H8N2O3S |
| Molecular Weight | 272.279 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/vet/lopatol-500-can.htmlCurator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/444159 and http://parasitipedia.net/index.php?option=com_content&view=article&id=2525&Itemid=2799
Sources: https://www.drugs.com/vet/lopatol-500-can.html
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/444159 and http://parasitipedia.net/index.php?option=com_content&view=article&id=2525&Itemid=2799
Nitroscanate (trade name Lopatol) is a medium-spectrum anthelmintic used on dogs and cats. It is available in the form of tablets for oral administration. It is not used on livestock. Nitroscanate is effective against the major gastrointestinal roundworms (nematodes) of dogs and cats (e.g.Toxocara canis, Toxocara cati, Ancylostoma spp, Uncinaria stenocephala) and tapeworms (e.g. Dipylidium caninum, Echinococcus granulosus, Taenia spp, etc.). The molecular mode of action of nitroscanate has not been elucidated. It is assumed that it acts as an uncoupler of the oxidative phosphorylation in the cell mitochondria, which disturbs the production of ATP, the cellular "fuel". This impairs the parasites motility and probably other processes as well.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006754 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Lopatol Approved UseLopatol is indicated for the treatment of infestations in dogs of:
Roundworms caused by Toxocara canis, Toxascaris leonina.
Hookworms caused by Ancylostoma caninum, Uncinaria stenocephala.
Tapeworms caused by Taenia spp., Dipylidium caninum. Launch Date1996 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Continuous feed medication with nitroscanate for the removal of Hymenolepis nana in naturally infected mice and rats. | 2001-10 |
|
| Oral pharmacological treatments for parasitic diseases of rainbow trout Oncorhynchus mykiss. II. Gyrodactylus sp. | 1998-07-30 |
|
| Nitroscanate A new broad spectrum anthelmintic against nematodes and cestodes of dogs and cats. | 1979-02 |
|
| The effect of micronised nitroscanate on Echinococcus granulosus and Taenia hydatigena infections in dogs. | 1977-05 |
|
| The effect of nitroscanate on Echinococcus granulosus and Taenia hydatigena infections in dogs. | 1975-09 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/vet/lopatol-500-can.html
For roundworms, hookworms and tapeworms.
50 mg/kg of body weight - one 100 mg tablet per 2 kg body weight
or - one 500 mg tablet per 10 kg body weight.
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.int-res.com/articles/dao/10/d010p039.pdf
In vitro, a concentration of 156.25 mg 1(-1) failed to kill all the helminths Gyrodactylus sp. obtained from rainbow trout, but in vivo all concentrations equal to, or greater than, 0.07 mg 1(-1) were 100% effective;
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:56:49 GMT 2025
by
admin
on
Wed Apr 02 08:56:49 GMT 2025
|
| Record UNII |
P4IE5B6D6U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QP52AX01
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
19881-18-6
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
C011042
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
P4IE5B6D6U
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
100000084142
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
CHEMBL304432
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
NITROSCANATE
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
DTXSID9048772
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
243-393-6
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
m7989
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB09328MIG
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
3730
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
C75226
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY | |||
|
68547
Created by
admin on Wed Apr 02 08:56:49 GMT 2025 , Edited by admin on Wed Apr 02 08:56:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |